LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test new drug duo in fight against spreading breast cancer
Disease control OngoingThis early-stage trial aims to find the safest and most effective dose of two drugs—cyclophosphamide and veliparib—when given together. It is for people with advanced breast cancer that has spread and is HER2-negative. The main goal is to understand the side effects and determine…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New combo attack on advanced breast cancer
Disease control OngoingThis study is testing whether adding an immunotherapy drug (atezolizumab) to a targeted cancer drug (olaparib) works better than the targeted drug alone for people with advanced breast cancer that has a specific genetic flaw (BRCA mutation). The goal is to see if the combination …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC